Erik Kellison, PharmD, BCPS, BCACP, BCCP
@erikkellison
Medical Science Liaison, Cardiovascular, Bristol Myers Squibb. Content is my own.
You might like
No, not yet on formulary. #SGLT2TweetCHat
In preparing for this talk, I was floored by all the excellent resources available to HF patients. Thank you @HFSA @American_Heart @ACCinTouch @Novartis @medlineplus @nih_nhlbi @CDCgov We can do better for our patients!
Just when you thought endothelial dysfunction was bad enough already for its involvement in a host of common, prevalent, chronic diseases, here it comes again, swinging for the bleachers.
Back to the roots: Covid is an endothelial disease; sure, the lungs are affected, but CV causes are as important for the outcome, i.e. VTE due to TF , ischemia in all organs - inflammation as the final common pathway leading to endothelial dysfunction: red it, it's worth it!
I ❤️ @escardio, @drjohnm, and #FOAMed Seven Quick Thoughts on the New European AF Guidelines Teaser medscape.com/viewarticle/93… via @medscape
#COVID-19 as an endothelial disease. An insightful viewpoint from Peter Libby and @TomLuscher academic.oup.com/eurheartj/arti… #cardiotwitter #CardioEd
Don’t stop those ACEI and ARBS in the #COVID19 patients. Just released from the @escardio meetings. @ACCinTouch #ACCCVT @accpcardprn @JGPharmD
#ESCCongress | BRACE CORONA: heart patients hospitalised with #COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs).
DIGOXIN is BACK! #RateAF trial. RCT: Bisoprolol vs Digoxin in permAF: similar HR reduction, BUT better daily functioning, better NYHA class/NT-proBNP and less clinical events. #Epeeps #cardiotwitter #ESCCongress
And here I thought I’d have to wait another 8 hours for this! Just waiting on FDA now... #SGLT2i #Empagliflozin for HFrEF. CKD. ASCVD. T2DM. Jeez. Also, interesting trend for more benefit in pts on #ARNI nejm.org/doi/pdf/10.105…
Cookbook Medicine Won't Cut It With New Drugs for HFrEF medscape.com/viewarticle/93… via @medscape
Maps on w/ clinical experience
Sacubitril/valsartan superior to valsartan alone for reduction of renal events in patients with #HFpEF and #CKD, study indicates. @CardiologyToday: bit.ly/2QcxtrI
healio.com
Sacubitril/valsartan improves renal outcomes in HFpEF, chronic kidney disease
Sacubitril/valsartan was superior to valsartan alone for reduction of renal events in patients with HF and preserved ejection fraction and chronic kidney disease, researchers reported.Sacubitril/va...
Inpatient initiation of sacubitril-valsartan for patients with HFrEF may be associated with reduced hospitalizations, increased quality-adjusted life expectancy, and cost savings compared with no initiation or initiation after hospitalization ja.ma/2CkHpfg
Targeting #cardiovascular inflammation: next steps in clinical translation bit.ly/3ad1ReC @escardio #EHJ #ESC_Young #cardiotwitter @ehj_ed
Diagnose of #HFpEF is challenging. H2FPEF or HFA-PEFF scores might help to identify high risks in unexplained dyspnea. Great paper @mvaduganathan et al Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community heartfailure.onlinejacc.org/content/8/8/640
United States Trends
- 1. Auburn 39K posts
- 2. Duke 30.5K posts
- 3. Bama 28.5K posts
- 4. Miami 122K posts
- 5. #SurvivorSeries 179K posts
- 6. Stockton 18.5K posts
- 7. Ole Miss 36.6K posts
- 8. Lane Kiffin 45.9K posts
- 9. Virginia 47.8K posts
- 10. Notre Dame 24.5K posts
- 11. Stanford 9,154 posts
- 12. Cam Coleman 1,839 posts
- 13. Austin Theory 4,588 posts
- 14. #RollTide 6,120 posts
- 15. Iron Bowl 16.2K posts
- 16. Cooper Flagg 6,993 posts
- 17. Ty Simpson 3,992 posts
- 18. ACC Championship 7,916 posts
- 19. Ryan Williams 1,748 posts
- 20. Seth 20.8K posts
Something went wrong.
Something went wrong.